Nonmyeloablative allogeneic transplantation with or without (90)yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

In 2008, we reported favorable 5-year outcomes of nonmyeloablative allogeneic stem cell transplantation after fludarabine, cyclophosphamide, rituximab (FCR) conditioning for relapsed and chemosensitive follicular lymphoma. However, innovative strategies were still needed to treat patients with chemo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Khouri, Issa F., Saliba, Rima M., Erwin, William D., Samuels, Barry I., Korbling, Martin, Medeiros, L. Jeffrey, Valverde, Rosamar, Alousi, Amin M., Anderlini, Paolo, Bashir, Qaiser, Ciurea, Stefan, Gulbis, Alison M., de Lima, Marcos, Hosing, Chitra, Kebriaei, Partow, Popat, Uday R., Fowler, Nathan, Neelapu, Sattva S., Samaniego, Felipe, Champlin, Richard E., Macapinlac, Homer A.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2012
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4347306/
https://ncbi.nlm.nih.gov/pubmed/22586182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-417808
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares